Chithandizo Chatsopano cha Zilonda zamapazi a Diabetic

A GWIRITSANI KwaulereKutulutsidwa 6 | eTurboNews | | eTN
Written by Linda Hohnholz

Advanced Oxygen Therapy Inc. (AOTI), yemwe ndi mtsogoleri wapadziko lonse lapansi wosasokoneza machiritso ochiritsa mabala a okosijeni, walengeza lero kuti walandila Chinese National Medical Products Administration (NMPA), yomwe imadziwika kuti China FDA, kuvomerezedwa chifukwa chapadera Chithandizo cha oxygen (CHIWIRI2). Kupanga kukhala njira yokhayo yokhayo yochiritsira mabala yokhazikika kuti ikwaniritse izi ndikulola kampaniyo kuti iyambe kutsatsa ku China ndi mnzake wakomweko.           

China ili ndi anthu ambiri padziko lonse lapansi omwe ali ndi Matenda a shuga ndipo zotsatira zake zimakhala za Diabetic Foot Ulcer (DFU). Bungwe la International Diabetes Federation likuyerekeza kuti 10.6% ya anthu akuluakulu aku China tsopano ali ndi matenda a shuga omwe ndi anthu 141 miliyoni. Izi zikuyimira 56%, kapena 50 miliyoni, kuwonjezeka kwa zaka zapitazi za 10 zokha.1 Ku China, zochitika zapachaka za DFU ndi Amputation posachedwapa zanenedwa kuti ndi 8.1% ndi 5.1% motsatira, zomwe zikuyimira zilonda za 11.4 miliyoni ndi 7.2 miliyoni odulidwa odulidwa omwe angathe kupewedwa chaka chilichonse.2

Thandizo lapadziko lonse la AOTI la TWO2 lovomerezeka padziko lonse lachipatala lasonyezedwa m'maphunziro apamwamba omwe asindikizidwa posachedwa a Randomized Controlled Trial ndi Real Word Evidence 3 kuti apereke machiritso olimba a DFU. Zomwe zimapangitsa kuti zilonda zichepe kasanu ndi kamodzi, ndikuchepetsa kopitilira 4% m'chipatala komanso kuchepa kwa 88% kwa odulidwa odulidwa omwe amawonedwa m'miyezi 71. Kuchiritsa kotereku kumapatsa odwala chiyembekezo chatsopano cha kusungidwa kwa miyendo, pomwe kumapereka kuchepa kwakukulu kwa kagwiritsidwe ntchito kazachipatala ndi zotsatira zake zopulumutsa zachuma.

Pulofesa Andrew Boulton, pulezidenti wakale wa European Association for the Study of Diabetes and Professor of Medicine pa University of Manchester, UK ndi University of Miami, USA, komanso Wapampando wa AOTI's Scientific and Clinical Advisory Board, anati: “Shuga ndi chimodzi. zadzidzidzi zomwe zikuchulukirachulukira padziko lonse lapansi m'zaka za zana la 21. Ndizosintha kwambiri kuti pamapeto pake mukhale ndi zithandizo zamankhwala zotsimikiziridwa ndichipatala monga TWO2 zomwe zimathandizira pazotsatira zovuta monga kugonekedwa m'chipatala ndi kudula ziwalo. Popeza kuti mankhwala a TWO2 ndi ololedwa ku China, anthu ambiri padziko lonse amene ali ndi zilonda za m’mapazi ali ndi chiyembekezo choti zinthu zidzayenda bwino.”

ZOMWE MUNGACHITE PA NKHANIYI:

  • Professor Andrew Boulton, past-President of the European Association for the Study of Diabetes and Professor of Medicine at the University of Manchester, UK and University of Miami, USA, and Chairman of AOTI’s Scientific and Clinical Advisory Board, commented.
  • Making it the only advanced sustained wound healing therapeutic to have achieved such a designation and allowing the company to now commence marketing in China with its local partner.
  • Resulting in six-fold reductions in ulcer recurrence, with an unprecedented 88% reduction in hospitalizations and 71% reduction in lower extremity amputations seen over 12 months.

Ponena za wolemba

Linda Hohnholz

Mkonzi wamkulu kwa eTurboNews zochokera ku eTN HQ.

Amamvera
Dziwani za
mlendo
0 Comments
Zolowetsa Pamakina
Onani ndemanga zonse
0
Mukufuna malingaliro anu, chonde yankhani.x
Gawani ku...